Coya Therapeutics, Inc. (COYA) Stock Statistics & Valuation Metrics

Coya Therapeutics, Inc. has a market cap or net worth of $94.06M. The enterprise value is $20.26M.

Coya Therapeutics, Inc. has 23,457,184 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coya Therapeutics, Inc.’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -45.98%.

The current PE Ratio of Coya Therapeutics, Inc. is ―. Coya Therapeutics, Inc.’s PEG ratio is -0.15.

In the last 12 months, Coya Therapeutics, Inc. had revenue of 7.95M and earned -21.23M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was -11.43B and capital expenditures 0.00, giving a free cash flow of -11.43B billion.

Coya Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Coya Therapeutics, Inc. upcoming earnings date is May 7, 2026, After Close (Confirmed).

Coya Therapeutics, Inc. as a current ratio of 8.50, with Debt / Equity ratio of 0.00%

In the past 12 months, Coya Therapeutics, Inc. has paid 3.09K in taxes.

Coya Therapeutics, Inc. EV to EBITDA ratio is -2.48, with an EV/FCF ratio of -4.68.

Coya Therapeutics, Inc. has $46.82M in cash and marketable securities with $0.00 in debt, giving a net cash position of $46.82M billion.

Gross margin is 99.66%, with operating margin of -255.05%, and net profit margin of -267.14%.

The average price target for Coya Therapeutics, Inc. is $16.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy